Viemed Healthcare Inc (VMD)
6.51 x 1 8.20 x 1
Post-market by (Cboe BZX)
7.27 +0.02 (+0.28%) 03/28/25 [NASDAQ]
6.51 x 1 8.20 x 1
Post-market 7.27 unch (unch) 16:02 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 17,540 | 12,839 | 16,914 | 28,408 | 30,981 |
Receivables | 24,911 | 18,451 | 15,405 | 14,716 | 12,373 |
Inventories | 4,320 | 4,628 | 3,574 | 2,457 | 2,310 |
TOTAL | $52,880 | $38,367 | $39,742 | $47,310 | $47,175 |
Non-Current Assets | |||||
PPE Net | 76,279 | 73,579 | 67,743 | 62,846 | 55,056 |
Investments And Advances | 2,794 | 3,899 | 4,155 | 2,157 | 733 |
Intangibles | 33,837 | 30,332 | 0 | 0 | 0 |
Other Non-Current Assets | 11,279 | 8,718 | 5,403 | 5,649 | 9,596 |
TOTAL | $124,189 | $116,528 | $77,301 | $70,652 | $65,385 |
Total Assets | $177,069 | $154,895 | $117,043 | $117,962 | $112,560 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 409 | 1,072 | N/A | 1,480 | 1,836 |
Accounts payable and accrued liabilities | 5,322 | 4,180 | 2,650 | 3,239 | 2,096 |
Accrued Expenses | 20,157 | 17,578 | 11,092 | 8,875 | 12,595 |
TOTAL | $37,326 | $32,124 | $18,861 | $17,811 | $23,017 |
Non-Current Liabilities | |||||
Long Term Debt | 3,589 | 6,002 | N/A | 4,306 | 5,796 |
Deferred Revenues | 6,694 | 6,207 | 4,624 | 3,753 | 3,409 |
aiOther Non-Current Liabilities | 2,709 | 2,742 | 1,088 | 757 | 1,292 |
TOTAL | $6,442 | $8,876 | $1,088 | $5,331 | $7,850 |
Total Liabilities | $43,768 | $41,000 | $19,949 | $23,142 | $30,867 |
Shareholders' Equity | |||||
Shares Outstanding, K | 39,522 | 38,757 | 38,169 | 39,680 | 39,562 |
Common Shares | 23,365 | 18,702 | 15,123 | 14,014 | 9,181 |
Retained earnings | 89,691 | 79,495 | 69,846 | 73,335 | 65,643 |
Other shareholders' equity | 1,908 | 0 | 0 | -278 | -451 |
TOTAL | $133,301 | $113,895 | $97,094 | $94,820 | $81,693 |
Total Liabilities And Equity | $177,069 | $154,895 | $117,043 | $117,962 | $112,560 |